logo

UTHR

United TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

UTHR Profile

United Therapeutics Corporation

A biotechnology company that develops and commercializes products to treat pulmonary arterial hypertension and other diseases

Biological Technology
--
06/17/1999
NASDAQ Stock Exchange
1,305
12-31
Common stock
1000 Spring Street, Silver Spring, MD 20910
--
United Therapeutics Corporation was founded in Delaware in 1996. It is a biotechnology company dedicated to the development and commercialization of unique products that address the unmet medical needs of patients with chronic diseases and life-threatening conditions. Its revenue is mainly derived from the sales of Quqian Liannier, Tyvaso and Tadalafil. Their marketing and sales staff will try to make their products available in their authorized countries. These are mainly done by their professional distributors in the United States and other international distributors.